Intellia Therapeutics, Inc. has grown revenue 7.3% a year over three years and 5.1% a year over five. Revenue growth, 3-year annual rate: +7.3% (Biotechnology median +21%). Revenue growth, 5-year rate: +5.1%, growth has picked up over the last three years. Years of annual history on file: 11, FY2015 to FY2025, as filed.

NTLAIntellia Therapeutics, Inc.

HealthcareUSD

$13.19

$8.0452 weeks$27.98

Is it growing?

Is NTLA growing?

Intellia Therapeutics, Inc. has grown revenue 7.3% a year over three years and 5.1% a year over five.

+7.3%

Revenue growth, 3-year annual rate · Biotechnology median +21% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +5.1%
Revenue growth, 5-year rate · +7.3% over three · growth has picked up over the last three years
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›